Blocking the CD47-SIRPα Axis enhances Tafasitamab-mediated phagocytosis

被引：0
|
作者：
Biedermann, A. [1 ]
Mangelberger-Eberl, D. [2 ]
Mougiakakos, D. [3 ]
Buettner-Herold, M. [4 ]
Patra-Kneuer, M. [2 ]
Flamann, C. [1 ]
Kellner, C. [5 ]
Peipp, M. [6 ]
Altmeyer, S. [7 ]
Bittenbring, J. [7 ]
Augsberger, C. [2 ]
Landgraf, K. [2 ]
Ilieva-Babinsky, K. [2 ]
Hasskamp, S. [8 ,9 ]
Beier, F. [10 ]
Lischer, C. [11 ]
Vera, J. [11 ]
Voelkl, S. [1 ]
Jacobs, B. [1 ]
Steidl, S. [2 ]
Heitmueller, C. [2 ]
Mackensen, A. [1 ]
Bruns, H. [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Hematol & Oncol 5, Erlangen, Germany
[2] MophoSys AG, Munich, Germany
[3] Otto von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany
[4] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Transfus Med Cell Therapeut & Haemostaseol, Munich, Germany
[6] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany
[7] Saarland Univ, Med Klin 1, Med Sch, Homburg, Germany
[8] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany
[9] Inst Human Genet, Erlangen, Germany
[10] RWTH Med Sch, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany
[11] Friedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P762
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [41] Blocking CD47-SIRPα Signaling Promotes the Phagocytic Activity of Macrophages Against Hepatocellular Carcinoma.
    Abe, T.
    Tanaka, Y.
    Tanimine, N.
    Kinren, P.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 375 - 375
  • [42] BLOCKING THE CD47-SIRP. AXIS IN NONALCOHOLIC STEATOHEPATITIS ENHANCES NECROPTOTIC HEPATOCYTE UPTAKE AND IMPROVES HEPATIC FIBROSIS
    Shi, Hongxue
    Wang, Xiaobo
    Moore, Mary P.
    Yurdagul, Arif
    Cai, Bishuang
    Valenti, Luca
    Tabas, Ira
    HEPATOLOGY, 2022, 76 : S664 - S665
  • [43] Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy
    Zhang, Jin
    Jin, Shenhe
    Guo, Xiaojun
    Qian, Wenbin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (11) : 4418 - 4426
  • [44] INHIBITION OF THE CD47-SIRP?. AXIS FOR CANCER THERAPY A META-ANALYSIS OF EMERGING CLINICAL DATA
    Son, Ji
    Hsieh, Rodney Cheng-En
    Lin, Heather
    Krause, Kate
    Yuan, Ying
    Biter, Amadeo
    Welsh, James
    Curran, Michael
    Hong, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1441 - A1441
  • [45] A POTENT MICROGLIAL RESPONSE TO BLOCKING THE CD47-SIRPα ANTI-PHAGOCYTIC AXIS OVERCOMES DEFICIENT MACROPHAGE RECRUITMENT DURING ANTI-CD47 IMMUNOTHERAPY AGAINST GLIOBLASTOMA
    Hutter, Gregor
    Theruvath, Johanna
    Graef, Claus Moritz
    Weissman, Irving
    Mitra, Siddhartha S.
    Cheshier, Samuel H.
    NEURO-ONCOLOGY, 2017, 19 : 243 - 244
  • [46] Blocking "don't eat me" signal of CD47-SIRPα in hematological malignancies, an in-depth review
    Russ, Atlantis
    Hua, Anh B.
    Montfort, William R.
    Rahman, Bushra
    Bin Riaz, Irbaz
    Khalid, Muhammad Umar
    Carew, Jennifer S.
    Nawrocki, Steffan T.
    Persky, Daniel
    Anwer, Faiz
    BLOOD REVIEWS, 2018, 32 (06) : 480 - 489
  • [47] Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy
    Hazama, Daisuke
    Yin, Yizhen
    Murata, Yoji
    Matsuda, Makoto
    Okamoto, Takeshi
    Tanaka, Daisuke
    Terasaka, Naohiro
    Zhao, Jinxuan
    Sakamoto, Mariko
    Kakuchi, Yuka
    Saito, Yasuyuki
    Kotani, Takenori
    Nishimura, Yoshihiro
    Nakagawa, Atsushi
    Suga, Hiroaki
    Matozaki, Takashi
    CELL CHEMICAL BIOLOGY, 2020, 27 (09): : 1181 - +
  • [48] Inhibition of CD47-SIRPα axis to enhance immunity against different molecular subtypes of breast cancer
    Ma, Xingru
    Hartman, Zachary
    Tsao, Li-Chung
    Wang, Tao
    Liu, Cong-Xiao
    Yang, Xiao
    Lei, Gangjun
    Wei, Junping
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Exploiting the CD47-SIRPα macrophage checkpoint to control polycythemia vera
    Lysenko, V.
    Schuerch, P.
    van Wijk, N. Wildner-Verhey
    Kovtonyuk, L.
    Manz, M. G.
    Skoda, R. C.
    Theocharides, A. P.
    SWISS MEDICAL WEEKLY, 2021, 151 : 12 - 12
  • [50] Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
    Xiao, Amy
    Akilov, Oleg E.
    CELLS, 2022, 11 (22)
12345